Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum.
Shi QuiTakashi TakeshitaAiko SuetaMai TomiguchiLisa Goto-YamaguchiKaori HidakaIkuko SuzuYutaka YamamotoHirotaka IwasePublished in: Breast cancer (Tokyo, Japan) (2021)
Compared to HER2-ECD levels, the clinical usefulness of HER2-CN ratio was somewhat inferior. Improved measurement methods and further examination of the association with long-term prognosis and the response to anti-HER2 treatment analyzed by HER2-CN and HER2-ECD assay are required.